explore -WSS

explore

author：focus 2025-09-14 18:30:20 - browse：44

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Moderna hits safety problems in bold bid to reinvent medicine

entertainment

WSS

In venture capital firm's success, lessons for turning crisis into profit

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Moderna hits safety problems in bold bid to reinvent medicine

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

'The Exorcist' director William Friedkin dead at 87

More regulation could be coming for drug ads

entertainment

explore

explore

BioMarin wins approval for gene therapy to treat hemophilia A

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

New air purifier tech could be key to improving indoor air quality

Moderna hits safety problems in bold bid to reinvent medicine

Medicare proposal to cover medical devices draws a mixed reaction

Sage's campaign to raise awareness of postpartum depression hits a nerve

Bright Health sells Medicare Advantage business to Molina

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Drug repurposing or repositioning? The language matters

At least 12 people were injured in a blast at a port in northwest Turkey

knowledge

Discs beat pads, tampons for heavy menstrual flow, new study shows

Sage's campaign to raise awareness of postpartum depression hits a nerve

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Discs beat pads, tampons for heavy menstrual flow, new study shows

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

hotspot

entertainment

entertainment

hotspot